Detalhe da pesquisa
1.
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Blood
; 139(19): 2931-2941, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007321
2.
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study.
Biol Blood Marrow Transplant
; 25(2): 256-264, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30205231
3.
CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
Biochim Biophys Acta
; 1853(2): 338-47, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25450979
4.
The survival of memory CD8 T cells that is mediated by IL-15 correlates with sustained protection against malaria.
J Immunol
; 190(10): 5128-41, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23589611
5.
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).
Ann Hematol
; 93(1): 47-55, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24149914
6.
Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells.
Blood
; 117(17): 4632-41, 2011 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21355088
7.
Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells.
Blood
; 116(20): 4284-7, 2010 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20625010
8.
A Primary Extracutaneous Presentation of Merkel Cell Carcinoma.
Cureus
; 14(8): e28088, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36134061
9.
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.
Blood Adv
; 2(24): 3572-3580, 2018 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563881
10.
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.
Clin Cancer Res
; 24(9): 2060-2073, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437791
11.
Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit.
Leuk Res
; 62: 51-55, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985622
12.
Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia.
J Am Geriatr Soc
; 64(10): 1988-1995, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27627675
13.
High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.
Leuk Res
; 39(9): 945-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26154683
14.
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.
J Clin Oncol
; 33(33): 3953-60, 2015 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26324368
15.
Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway.
Exp Hematol
; 38(6): 472-80, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20303384